Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma.
Binghao LiGuoqi LiXiaobo YanDan ZhuPatrick P LinZenan WangHao QuXuexin HeYanbiao FuXiuliang ZhuPeng LinJiangnan ZhangXiaoya LiHui DaiHuabiao ChenMark C PoznanskyNong LinZhaoming YePublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
This study is the first to provide immune characterization of CHS, representing a major step to precise immunotherapy against this malignancy. Immunotherapy is promising for the "immune exhausted" subtype of patients with CHS.
Keyphrases